These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
672 related items for PubMed ID: 7628776
1. Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins? Agnelli G. Haematologica; 1995; 80(2 Suppl):78-83. PubMed ID: 7628776 [No Abstract] [Full Text] [Related]
5. [Therapy of thromboses with low-molecular-weight heparins]. Haas S, Haas P. Wien Med Wochenschr; 1999 Oct; 149(2-4):39-45; discussion 45. PubMed ID: 10378321 [Abstract] [Full Text] [Related]
6. Low molecular weight heparins (LMWH) in the treatment of patients with acute venous thromboembolism. Hirsh J, Siragusa S, Cosmi B, Ginsberg JS. Thromb Haemost; 1995 Jul; 74(1):360-3. PubMed ID: 8578485 [Abstract] [Full Text] [Related]
7. [Conventional or low molecular weight heparin in the treatment of venous thromboembolic disease?]. Ruiz Manzano J, Monreal M. Med Clin (Barc); 1998 Nov 28; 111(18):697-9. PubMed ID: 9887434 [No Abstract] [Full Text] [Related]
8. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes]. MMW Fortschr Med; 2003 Jun 12; 145(24):56. PubMed ID: 12866309 [No Abstract] [Full Text] [Related]
10. [Prevention of thrombosis in gynecology: double-blind comparison of low molecular weight heparin and unfractionated heparin]. Heilmann L, Kruck M, Schindler AE. Geburtshilfe Frauenheilkd; 1989 Sep 12; 49(9):803-7. PubMed ID: 2553528 [Abstract] [Full Text] [Related]
11. Low molecular weight heparins: prophylaxis of venous thromboembolism in surgical patients. Kakkar VV. Semin Hematol; 1997 Oct 12; 34(4 Suppl 4):9-19. PubMed ID: 9399405 [No Abstract] [Full Text] [Related]
12. Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Koch A, Bouges S, Ziegler S, Dinkel H, Daures JP, Victor N. Br J Surg; 1997 Jun 12; 84(6):750-9. PubMed ID: 9189079 [Abstract] [Full Text] [Related]
16. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis. Couturaud F, Julian JA, Kearon C. Thromb Haemost; 2001 Oct 12; 86(4):980-4. PubMed ID: 11686355 [Abstract] [Full Text] [Related]
17. Comparison of the relative efficacy and safety of low molecular weight heparin and unfractionated heparin for the treatment of deep venous thrombosis. Hirsh J. Semin Hematol; 1997 Oct 12; 34(4 Suppl 4):20-5. PubMed ID: 9399406 [No Abstract] [Full Text] [Related]
18. Management of venous thromboembolic disease. The impact of low-molecular-weight heparin. Tapson VF, Hull RD. Clin Chest Med; 1995 Jun 12; 16(2):281-94. PubMed ID: 7656540 [Abstract] [Full Text] [Related]
19. [Low molecular weight heparin: favorable effect profile for prevention and therapy of venous thrombosis]. Marbet GA. Ther Umsch; 1992 Dec 12; 49(12):843-9. PubMed ID: 1336627 [Abstract] [Full Text] [Related]
20. [Deep venous thrombosis--treatment]. Fries R, Böhm M. Dtsch Med Wochenschr; 2003 May 02; 128(18):999-1002. PubMed ID: 12721879 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]